On the 11th of March, the U.S. Food and Drug Administration announced that it needed $7.2 billion for the upcoming fiscal year 2025. The amount of requested funds is $495 million more than FDA has received for the current fiscal year which finishes on the 30th of September 2024.

“The FDA continues to protect the health and well-being of millions of people,” said FDA Commissioner Robert M. Califf, M.D.

This new funding request will help us build on our accomplishments and also modernize our agency and operations as we plan for the future. Our request for critical investments will help us address our most urgent priorities, strengthen our public health capacity, advance IT capabilities, and improve agency-wide infrastructure. 

“The budget will also support the FDA’s ability to prepare for, build resilience to, and respond to shortages, support the implementation of expanded cosmetics regulation, and protect and promote a safe, nutritious U.S. food supply,” Mr Califf added.

The agency reported that different levels of funding will go towards key areas, outlined as follows: 

• $15 million on food safety and nutrition to protect and promote a safe, nutritious U.S. food supply
• $12.3 million on shortages and supply chain to address supply-chain disruptions and support supply chain resiliency
• Bolstering modernisation efforts and mission support which includes:
  • $114.8 million to support the public health employee workforce
  • $8 million in additional funds to support the implementation of the Modernization of Cosmetics Regulation Act (MoCRA).
  • $2 million increase to support agency modernization activities.
  • $8.3 million to modernize data infrastructure to best support agency operations.
  • $1 million to expand foreign offices and strengthen imported products oversight.
• Infrastructure, Buildings, and Facilities which includes:
  • $43.6 million to ensure optimal functioning of the FDA’s offices and labs.